Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Relief Therapeutics Holding AG (RLFTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0272+0.0012 (+4.81%)
At close: 03:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0260
Open0.0284
BidN/A x N/A
AskN/A x N/A
Day's Range0.0265 - 0.0299
52 Week Range0.0230 - 0.1400
Volume367,085
Avg. Volume1,270,888
Market Cap119.906M
Beta (5Y Monthly)-17.26
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • InvestorPlace

    RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?

    Swiss biopharmaceutical company Relief Therapeutics (OTCMKTS:RLFTF) is up 31% today after its U.S. commercial partner NRx Pharmaceuticals (NASDAQ:NRXP) filed for emergency-use authorization with the U.S. Food and Drug Administration (FDA) for its Covid-19 treatment. Source: Shutterstock.com In a news release, NRx Pharmaceuticals said that it has submitted an application for EUA to the FDA for the use of its drug Zyesami. The company developed it for patients with Covid-19 who are at immediate ri

Advertisement
Advertisement